Search Results 1401-1410 of 17831 for monoclonal antibody

1. A Study Of ABBV-383 With Relapsed Refractory Waldenström Macroglobulinemia - Mayo Clinic

   Subject is naïve to treatment with ABBV-383 or anti-BCMA bispecific antibodies. ... Received a monoclonal antibody given with anti-neoplastic intent ≤30 days ...

2. A Study of PY314 in Subjects With Advanced Solid Tumors - Mayo Clinic

   monoclonal antibody therapy (except for bone-modifying agents as supportive care), radiotherapy, or any other agents to treat cancer within 21 days ...

3. Haemophilus b polysaccharide vaccine (intramuscular route, injection route) - Side effects & dosage - Mayo Clinic

   These illnesses include asplenia, sickle cell disease, antibody deficiency syndromes, immunosuppression, and Hodgkin's disease. Children 18 to 24 months of ...

4. A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion - Mayo Clinic

   (dFLC) >= 50 mg/L. - Has previously been exposed to a proteasome inhibitor (PI) and an anti-CD38 monoclonal antibody. Exclusion Criteria: - Known history of ...

5. A Randomized, Double-blind, Placebo-controlled Study To Investigate The Efficacy And Safety Of Depemokimab In Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

   Participants with an allergy/ intolerance to a monoclonal antibody or biologic, or any of the excipients of the investigational product. Monoclonal antibodies ...

6. Medical Research & Education - Mayo Clinic News Network

   Mayo Clinic expert answers questions about antibody testing for COVID-19 ... Science Saturday: Antibody testing, in pictures featured image. Research.

7. Medical Research & Education - Mayo Clinic News Network

   Mayo Clinic expert answers questions about antibody testing for COVID-19 ... Science Saturday: Antibody testing, in pictures featured image. Research.

8. Clinical trials - Oncology (Medical)

   UP-NEXT is a double-blind, randomized, placebo controlled study of the antibody-drug conjugate (ADC) XMT-1536 (upifitamab rilsodotin) administered as an ...

9. Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients (SAFE KIDNEY II) - Mayo Clinic

   Recipients who, in the opinion of the investigator, are likely to require antibody-depletion therapy during trial participation. Antibody-depleting ...

10. Combination Study of SV-BR-1-GM in Combination With INCMGA00012 and Retifanlimab - Mayo Clinic

    Known hypersensitivity to another monoclonal antibody that cannot be controlled with standard measures (e.g., antihistamines and corticosteroids) or known ...